AQUAURO and AQUAENDO, born from the idea of using water as therapy, launched on the Italian market in February 2018 for two medical targets. AQUAURO, aimed at urologists and gynecologists and approved by the Italian Society of Urology, offers a balanced physical-chemical composition for patients with urinary system diseases, with a pediatric version, AQUAURO-PED, available since 2019. AQUAENDO, aimed at endocrinologists and dietologists and approved by the Italian Society of Endocrinology, is designed for patients with obesity and endocrine system disorders. Both products combine three water sources located in Vinadio, in the western Italian Alps, and are owned by Swiss company Setthim.
No comments available.
Leave your rating & comment